Скачать или смотреть CRDG Webinar – Strengthening Cannabinoid R&D – Recording

Watch this insightful webinar, recorded on 21st October 2024, which discusses the findings of the Cannabinoid Research and Development Group's (CRDG) latest report, Strengthening Cannabinoid Research & Development: Controlled Drugs Licensing Reforms for UK Medical and Scientific Research in Academia and Industry.

The report, authored by Professor Trevor Jones CBE FMedSci and Zack Bellman, reveals critical delays in cannabinoid clinical trials due to outdated and complex licensing regulations by the UK Home Office. The report is now available to download on crdg.uk.

In this webinar, key experts, including Dr. Andy Yates, Chief Scientific Officer at Artelo Biosciences with Clarissa Sowemimo-Coker and Rob Bennett from Oxford Cannabinoid Technologies, will delve into the challenges facing cannabinoid research in the UK and explore how regulatory reforms could unlock opportunities for groundbreaking medical treatments.

Panel:
Dr Andy Yates, Chief Scientific Officer at Artelo Biosciences
Clarissa Sowemimo-Coker, Chief Executive Officer at Oxford Cannabinoid Technologies
Rob Bennett, General Counsel at Oxford Cannabinoid Technologies
Zack Bellman, Lead Researcher at CRDG

Host: Dr Elisabeth Philipps, Advisory Board member at CRDG